Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
38,33 USD | +0,42% | +1,00% | +33,65% |
09/05 | REVOLUTION MEDICINES, INC. : Wedbush è per il Buy | ZM |
08/05 | La perdita netta Q1 di Revolution Medicines si riduce | MT |
Attività
Numero di dipendenti: 411
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Targeted Therapies
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 35 | 100,0 % | 12 | 100,0 % | -67,27% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Jack Anders
DFI | Director of Finance/CFO | 47 | 01/08/18 |
Wally Reiher
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/15 |
Wei Lin
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/04/23 |
Steve Kelsey
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/03/17 |
Peg Horn
COO | Chief Operating Officer | 61 | - |
Linnet Zia
PRN | Corporate Officer/Principal | - | 01/03/19 |
Jeff Cislini
LAW | General Counsel | 49 | 01/01/20 |
Daniel Simon
PRN | Corporate Officer/Principal | - | 01/09/22 |
Xiao Lin Wang
PRN | Corporate Officer/Principal | 53 | 01/03/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Mark Goldsmith
CEO | Chief Executive Officer | 62 | 01/10/14 |
Alexis Borisy
BRD | Director/Board Member | 52 | 01/11/14 |
Sandra Horning
BRD | Director/Board Member | 75 | 09/11 |
Barbara Weber
BRD | Director/Board Member | 67 | 01/04/18 |
Thilo Schroeder
BRD | Director/Board Member | 42 | 01/03/18 |
Lorence Kim
BRD | Director/Board Member | 49 | 12/07/22 |
Director/Board Member | 66 | 01/03/15 | |
Flavia Borellini
BRD | Director/Board Member | 64 | 22/06/21 |
Sushil Patel
BRD | Director/Board Member | 52 | 16/06/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 170 546 280 | 160 457 305 ( 94,08 %) | 5 560 053 ( 3,260 %) | 94,08 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+33,65% | 6,32 Mrd | |
+43,36% | 54,63 Mrd | |
-5,31% | 39,92 Mrd | |
+14,75% | 26,86 Mrd | |
-12,56% | 26,22 Mrd | |
-22,45% | 18,78 Mrd | |
+25,12% | 12,21 Mrd | |
+0,04% | 12,16 Mrd | |
+26,04% | 11,94 Mrd | |
-11,83% | 10,74 Mrd |
- Borsa valori
- Azioni
- Azione RVMD
- Società Revolution Medicines, Inc.